Vor Biopharma Stock Analysis

Vor Stock Analysis Notes

About 81.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.75. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vor Biopharma recorded a loss per share of 1.64. The entity had not issued any dividends in recent years. Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Vor Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 135 people. For more information please call MBA MD at 617 655 6580 or visit https://www.vorbio.com.

Vor Biopharma Investment Alerts

Vor Biopharma Upcoming and Recent Events

Vor Largest EPS Surprises

View All Earnings Estimates

Vor Stock Institutional Investors

Note, although Vor Biopharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vor Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 54.67 M.

Vor Profitablity

Management Efficiency

Vor Biopharma has Return on Asset of (0.3974) % which means that on every $100 spent on assets, it lost $0.3974. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.7807) %, meaning that it generated no profit with money invested by stockholders. Vor Biopharma's management efficiency ratios could be used to measure how well Vor Biopharma manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/22/2024, Return On Tangible Assets is likely to drop to -0.62. In addition to that, Return On Capital Employed is likely to drop to -0.72. As of 11/22/2024, Net Tangible Assets is likely to grow to about 302.6 M, while Total Assets are likely to drop slightly above 151.6 M.

Technical Drivers

As of the 22nd of November, Vor Biopharma has the Coefficient Of Variation of (2,617), variance of 28.26, and Risk Adjusted Performance of (0.02). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vor Biopharma, as well as the relationship between them. Please validate Vor Biopharma market risk adjusted performance and treynor ratio to decide if Vor Biopharma is priced more or less accurately, providing market reflects its prevalent price of 0.8 per share. Given that Vor Biopharma is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Vor Biopharma Price Movement Analysis

Vor Biopharma Insider Trading Activities

Vor Biopharma Outstanding Bonds

Vor Biopharma Predictive Daily Indicators

Vor Biopharma Forecast Models

Vor Biopharma's time-series forecasting models are one of many Vor Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vor Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vor Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vor shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vor Biopharma. By using and applying Vor Stock analysis, traders can create a robust methodology for identifying Vor entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vor analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vor analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Vor Biopharma stock analysis indicators help investors evaluate how Vor Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vor Biopharma shares will generate the highest return on investment. By understating and applying Vor Biopharma stock analysis, traders can identify Vor Biopharma position entry and exit signals to maximize returns.

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.